Recce Pharmaceuticals (ASX:RCE) - Vice President of Translational Sciences, Dr Philip Sutton
Vice President of Translational Sciences, Dr Philip Sutton
Source: Philip Sutton/LinkedIn
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Recce Pharmaceuticals (RCE) appoints Dr Philip Sutton as Vice President of Translational Sciences
  • This role will take responsibility for advancing the company’s compounds across a portfolio of infectious disease programs with unmet medical needs
  • Dr Sutton has been involved with Recce since August 2020, when he investigated the potential of the company’s anti-infectives across multiple pre-clinical programs
  • Prior to this, he was Head of Immunology at CSL (CSL) in Melbourne and has co-authored 99 peer-reviewed publications
  • Shares are trading steady at 80 cents at 2:07 pm AEST

Recce Pharmaceuticals (RCE) has appointed Dr Philip Sutton as Vice President of Translational Sciences.

Within this role, Dr Sutton will work to advance the company’s compounds across a portfolio of infectious disease programs with unmet medical needs.

He has been involved with Recce since August 2020, when he investigated the potential of the company’s anti-infectives across multiple pre-clinical programs.

Prior to this, he was Head of Immunology at CSL (CSL) in Melbourne and has co-authored 99 peer-reviewed publications.

CEO James Graham said he was pleased with the appointment.

“Dr Sutton joins us at an exciting time as our clinical programs continue to advance and welcome his contributions to the pipeline development of our new class of anti-infectives,” he said.

Shares were trading steady at 80 cents at 2:07 pm AEST.

RCE by the numbers
More From The Market Herald
The Market Herald Video

" New Age Exploration (ASX:NAE) granted Marlborough project, NZ

New Age Exploration (ASX:NAE) is granted a prospecting permit which covers the Marlborough gold project in…
Melbana Energy (ASX:MAY) - Executive Chairman, Andrew Purcell (left)

" Melbana Energy (ASX:MAY) drilling reaches 2.15km MD at Zapato-1

Melbana Energy (ASX:MAY) has reached a depth of 2.15 kilometres at the side-track hole in its…

" Metgasco (ASX:MEL) flags $5.9m buyout of Patriot Hydrogen

Metgasco (ASX:MEL) is set to purchase waste-to-hydrogen production business Patriot Hydrogen for $5.9 million as part…
Horizon Minerals (ASX:HRZ) - Managing Director, Jon Price

" Horizon Minerals (ASX:HRZ) gets “excellent” drill results at Monument, WA

Horizon Minerals (ASX:HRZ) reports "excellent" results from the Monument gold prospect in WA.